Literature DB >> 6436381

The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).

R A Miller, J Gralow.   

Abstract

Malignant cells from five patients with B cell leukemia or lymphoma were cultured with phorbol myristic acetate (PMA). PMA was found to induce cell surface expression of the Leu-1 antigen in cells from three of the five patients. Using one- and two-color immunofluorescence staining and flow cytometry, we have shown simultaneous expression of the Leu-1 antigen with other B cell markers. Induction of Leu-1 antigen expression was not related to histologic subtype, in vitro secretion of immunoglobulin, or other clinical features. Biosynthetic labeling experiments showed that synthesis of Leu-1 antigen occurred and preceded expression of the antigen on the cell surface. PMA also induced the appearance of Leu-1 antigen-positive B cells in cultures of normal peripheral blood mononuclear cells. We propose that the Leu-1 antigen is expressed transiently during the differentiation of some B cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436381

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation.

Authors:  D Kaplan; D Smith; H Meyerson; N Pecora; K Lewandowska
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

2.  Synthesis of anti-acetylcholine receptor antibodies by CD5- B cells from peripheral blood of myasthenia gravis patients.

Authors:  F Heidenreich; T Jovin
Journal:  J Neurol       Date:  1996-01       Impact factor: 4.849

3.  Induction of murine CD5 expression by v-H-ras.

Authors:  T R Weichert; R C Schwartz
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia.

Authors:  A H Maddy; A Sanderson; M J Mackie; S K Smith
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

5.  B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis.

Authors:  E Mix; T Olsson; J Correale; S Baig; V Kostulas; O Olsson; H Link
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

6.  Detection of lymphocyte subsets using three-color/single-laser flow cytometry and the fluorescent dye peridinin chlorophyll-alpha protein.

Authors:  B Afar; J Merrill; E A Clark
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

Review 7.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  B lymphocyte reconstitution after human bone marrow transplantation. Leu-1 antigen defines a distinct population of B lymphocytes.

Authors:  J H Antin; K A Ault; J M Rappeport; B R Smith
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Characterization of porcine CD5 and CD5+ B cells.

Authors:  G D Appleyard; B N Wilkie
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

10.  Comparable profiles of the immunoglobulin heavy chain complementarity determining region (CDR)-3 in CD5+ and CD5- human cord blood B lymphocytes.

Authors:  H Kiyoi; K Naito; R Ohno; T Naoe
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.